Ying Ju, Chang-Ming Wang, Juan-Juan Yu, Xue Li, Ming-Xin Qi, Jiahui Ren, Ying Wang, Pei Liu, Yuan Zhou, Yu-Xiang Ma, Guang Yu
European journal of pharmacology 2024 Feb 05Pain is the cardinal symptom of many debilitating diseases and results in heavy health and economic burdens worldwide. Asarum (Asarum sieboldii Miq.) is a commonly used analgesic in Chinese medicine. However, the analgesic components and mechanisms of asarum in acute and chronic pain mice model remain unknown. In this study, we first generated asarum water extract and confirmed strong analgesic properties in mice in both the acute thermal and mechanical pain models, as well as in the complete Freund's adjuvant (CFA) induced chronic inflammatory pain model. Second, we identified higenamine as a major component of asarum and found that higenamine significantly inhibited thermal and mechanical induced acute pain and CFA induced chronic inflammatory pain. Then, using Trpv4-/- mice, we found that TRPV4 is necessary for CFA induced thermal and mechanical allodynia, and demonstrated that higenamine analgesia in the CFA model is partly through TRPV4 channel inhibition. Finally, we found that GSK1016790A, a TRPV4 agonist, induced calcium response was significantly inhibited by higenamine in both cultured DRG neurons and TRPV4 transfected HEK293 cells. Consistent with calcium imaging results, higenamine pretreatment also dose-dependently inhibited GSK1016790A induced acute pain. Taken together, our behavior and calcium imaging results demonstrate that the asarum component higenamine inhibits acute and chronic inflammatory pain by modulation of TRPV4 channels. Copyright © 2024 Elsevier B.V. All rights reserved.
Ying Ju, Chang-Ming Wang, Juan-Juan Yu, Xue Li, Ming-Xin Qi, Jiahui Ren, Ying Wang, Pei Liu, Yuan Zhou, Yu-Xiang Ma, Guang Yu. Higenamine inhibits acute and chronic inflammatory pain through modulation of TRPV4 channels. European journal of pharmacology. 2024 Feb 05;964:176295
Mesh Tags
Substances
PMID: 38154768
View Full Text